Back
Viking Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Sell
40
VKTX
Viking Therapeutics
Last Price:
51.29
Seasonality Move:
92.31%
Buy
57
LLY
Eli Lilly and
Last Price:
829.93
Seasonality Move:
5.03%
Sell
40
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $50.26. The Score for VKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $813.33. The Score for LLY is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $50.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $813.33
The current trend is relatively stagnant and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.56 | Sell |
Relative Strength Index (14 RSI): | 35.79 | Sell |
Chaikin Money Flow: | -78713 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.59 - 67.35) | Sell |
Bollinger Bands (100): | (53.86 - 67.16) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -16.91 | Sell |
Relative Strength Index (14 RSI): | 52.51 | Buy |
Chaikin Money Flow: | 1405271 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (754.58 - 834.34) | Buy |
Bollinger Bands (100): | (808.8 - 936.02) | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.36 | Sell |
20-day SMA: | 56.03 | Sell |
50-day SMA: | 62.07 | Sell |
200-day SMA: | 62.86 | Sell |
8-day EMA: | 52.38 | Sell |
20-day EMA: | 55.68 | Sell |
50-day EMA: | 59.51 | Sell |
200-day EMA: | 55.4 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 779.87 | Buy |
20-day SMA: | 782.81 | Buy |
50-day SMA: | 850 | Sell |
200-day SMA: | 836.27 | Sell |
8-day EMA: | 788.45 | Buy |
20-day EMA: | 794.69 | Buy |
50-day EMA: | 831.29 | Sell |
200-day EMA: | 809.9 | Buy |
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.88 per share, and an increase next year of $9.35 per share.
Viking Therapeutics Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |